Concepedia

Stanislav Huszár

SH

Statistics

Publications

12

Citations

812

H-Index

12

Active since

2013

Affiliations

Comenius University Bratislava(Current)

University of Pavia

École Polytechnique Fédérale de Lausanne

A N Bach Institute of Biochemistry

GlaxoSmithKline (Spain)

Stanislav Huszár is an author at Comenius University Bratislava specializing in drug discovery, pharmacology, and enzyme inhibition.

ORCID

Publications per year

2013–2021

12

Publications

12

Identification of a small molecule with activity against drug-resistant and persistent tuberculosis

Feng Wang, Dhinakaran Sambandan, Rajkumar Halder et al. · Proceedings of the National Academy of Sciences · 2013 · 226 citations · Full text

, , +17

DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization

Miroslav Brecik, Ivana Centárová, Raju Mukherjee et al. · ACS Chemical Biology · 2015 · 162 citations · Full text

, , +13

The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis

Vadim Makarov, João Neres, Ruben C. Hartkoorn et al. · Antimicrobial Agents and Chemotherapy · 2015 · 79 citations · Full text

, , +15

Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-<scp>d</scp>-ribofuranose 2′-Oxidase

Galina Karabanovich, Ján Dušek, Karin Savková et al. · Journal of Medicinal Chemistry · 2019 · 62 citations

, , +16

A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK

Laurent R. Chiarelli, Giorgia Mori, Béatrice Silvia Orena et al. · Scientific Reports · 2018 · 53 citations · Full text

, , +14

1–5 of 12